Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC
NCT04094909
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
186
Enrollment
OTHER
Sponsor class
Conditions
Staging IV NSCLC
Interventions
DRUG:
Rh-endostatin
Sponsor
Guangzhou Institute of Respiratory Disease